MOTS-c
unknown riskAlso: Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c is a mitochondria-derived peptide (MDP) encoded within the 12S rRNA gene. It acts as an exercise mimetic, activating AMPK and improving metabolic flexibility, with emerging evidence for anti-aging properties.
Reported Benefits
Metabolic Enhancement
Activates AMPK, improves insulin sensitivity, and mimics exercise adaptations in animal models.
Exercise Mimetic
Mice receiving MOTS-c show improved exercise performance and metabolic adaptation without training.
Anti-aging
Preliminary data links MOTS-c decline to aging-related metabolic dysfunction.
Mechanism of Action
MOTS-c enters the cell nucleus and regulates metabolic gene expression, activating AMPK (the cellular energy sensor) and the folate cycle/AICAR pathway. This drives mitochondrial biogenesis, improved glucose metabolism, and anti-inflammatory gene expression changes.
Key Clinical Studies
Lee C et al. (2015)
animal · Mice
MOTS-c activates AMPK, reverses diet-induced obesity
Reynolds JC et al. (2021)
animal · Aged mice
MOTS-c improves physical performance in old mice
Overview
MOTS-c is one of the most intriguing recently discovered mitochondria-derived peptides. Its classification as an “exercise mimetic” — producing metabolic adaptations similar to physical exercise without exercise itself — has attracted significant attention from both anti-aging researchers and sports medicine communities.
AMPK Connection
The central mechanism — AMPK activation — connects MOTS-c to one of the most well-validated metabolic pathways in biology. Metformin (the most prescribed diabetes drug) works partly through AMPK. Caloric restriction extends lifespan partly through AMPK. MOTS-c activating this pathway through mitochondrial signaling represents a novel upstream entry point.
Human Data Gap
Unlike humanin (which has some human data), MOTS-c is entirely in preclinical stages. No completed human trials exist. The mechanism is compelling and the animal data is promising, but translation to human benefit at safe doses remains undemonstrated.
Nuclear Translocation
A fascinating feature of MOTS-c is its ability to translocate to the cell nucleus and directly regulate gene expression — a property not expected from a mitochondrially derived peptide. This nuclear activity may account for the breadth of its metabolic effects and represents an active area of mechanistic investigation.
Regulatory Status
Research OnlyNot FDA-approved; preclinical research stage; no clinical trials completed
Safety Profile
Side Effects
- •No significant adverse effects in animal studies
Contraindications
- •Pregnancy (insufficient data)
Drug Interactions
- •Metformin (AMPK overlap, potentially synergistic)
Primary Uses
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe MOTS-c?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →